Journal of Clinical and Translational Hepatology

Papers
(The median citation count of Journal of Clinical and Translational Hepatology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Development and Validation of a Nomogram for Prediction of the Risk of MAFLD in an Overweight and Obese Population114
Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma73
Fas/FasL and Complement Activation are Associated with Chronic Active Epstein-Barr Virus Hepatitis46
The Impact of Liver Graft Preservation Method on Longitudinal Gut Microbiome Changes Following Liver Transplant: A Proof-of-concept Study42
Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research35
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma29
CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis28
1,5-Anhydroglucitol Predicts Mortality in Patients with HBV-Related Acute-on-chronic Liver Failure26
Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis26
Comparison of Clinical Characteristics and Outcomes of MAFLD and NAFLD in Chinese Health Examination Populations25
GPX4 Promoter Hypermethylation Induced by Ischemia/Reperfusion Injury Regulates Hepatocytic Ferroptosis25
Evaluation of Plasma Neurodegenerative Biomarkers for Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy in Chinese Patients with Hepatic Cirrhosis25
Subnormal Serum Liver Enzyme Levels: A Review of Pathophysiology and Clinical Significance22
Autoimmune Hepatitis Induced after Treatment of Syphilitic Hepatitis21
Role of Exosomal Modulation of Macrophages in Liver Fibrosis20
A Prognostic Nomogram for Hepatocellular Carcinoma Based on Wound Healing and Immune Checkpoint Genes19
Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment19
Booster Vaccination in Infancy Reduces the Incidence of Occult HBV Infection in Maternal HBsAg-positive Children17
Dose-dependent Relationship between Alcohol Consumption and the Risks of Hepatitis B Virus-associated Cirrhosis and Hepatocellular Carcinoma: A Meta-analysis and Systematic Review17
Development and Validation of a Nomogram for 90-day Outcome in Patients with Hepatitis B Virus-related Acute-on-chronic Liver Failure16
Gut Microbiota Dysbiosis Strengthens Kupffer Cell-mediated Hepatitis B Virus Persistence through Inducing Endotoxemia in Mice15
Oncolytic Virus Senecavirus A Inhibits Hepatocellular Carcinoma Proliferation and Growth by Inducing Cell Cycle Arrest and Apoptosis15
Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis15
Irreversible Electroporation for Hepatocellular Carcinoma Abutting the Diaphragm: A Prospective Single-center Study14
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link14
Gut Microbiota and Cytokine Profile in Cirrhosis14
Ferrochelatase Gene Variants Associated with Cholestasis in Adults: A Case Report13
Decoding 17-Beta-hydroxysteroid Dehydrogenase 13: A Multifaceted Perspective on Its Role in Hepatic Steatosis and Associated Disorders13
Progress in the Correlation Between Inflammasome NLRP3 and Liver Fibrosis13
Ursodeoxycholic Acid for the Management of Drug-induced Liver Injury: Role of Hepatoprotective and Anti-cholestatic Mechanisms13
FOXO1 Alleviates Liver Ischemia-reperfusion Injury by Regulating the Th17/Treg Ratio through the AKT/Stat3/FOXO1 Pathway12
Premorbid Steatohepatitis Increases the Seriousness of Dextran Sulfate Sodium-induced Ulcerative Colitis in Mice12
Role of Hydrogen Sulfide and Hypoxia in Hepatic Angiogenesis of Portal Hypertension12
SGLT-2 Inhibitor and GLP-1 Receptor Agonist Treatment for Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Is Their Combination the Optimal Treatment Option?12
Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome12
Chinese Clinical Practice Guidelines for the Prevention and Treatment of Mother-to-child Transmission of Hepatitis B Virus (Version 2024)12
Transcriptomic Landscape Analysis Reveals a Persistent DNA Damage Response in Metabolic Dysfunction-associated Steatohepatitis Post-dietary Intervention12
Hepatocellular Carcinoma with Gastric Metastasis Mimicking a 4 cm Gastrointestinal Stromal Tumor After a 3-year Disease-free Interval11
Relationship between the Level of Serum Golgi Protein 73 and the Risk of Short-term Death in Patients with ALD-ACLF11
Single-cell RNA-seq Revealed that Altered Tumor Infiltrating Lymphocytes in Cirrhotic Liver Indicate Development of Hepatocellular Carcinoma11
Noninvasive Fibrosis Assessment in Chronic Hepatitis C Infection: An Update11
Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry10
Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease10
SOX9 Overexpression Ameliorates Metabolic Dysfunction-associated Steatohepatitis Through Activation of the AMPK Pathway10
Characteristics of a Chinese Cohort of Patients with Chronic Hepatitis C Infection (2019–2023) and a Case Report of Resistance-associated Substitutions to Sofosbuvir-velpatasvir Treatment10
A Novel Backward Stepwise Logistic Regression and Classification and Regression Tree Model to Predict 180-day Clinical Outcomes in Hepatitis B Virus-Acute-on-Chronic Liver Failure Patients10
Systematic Training of Liver Imaging Reporting and Data System Magnetic Resonance Imaging v2018 can Improve the Diagnosis of Hepatocellular Carcinoma for Different Radiologists10
Journal of Clinical and Translational Hepatology 10th Anniversary Editorial10
Secondary Iron Overload and the Liver: A Comprehensive Review10
Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis10
Ferroptosis and Intrinsic Drug-induced Liver Injury by Acetaminophen and Other Drugs: A Critical Evaluation and Historical Perspective9
The Therapeutic Effects of Baicalein on the Hepatopulmonary Syndrome in the Rat Model of Chronic Common Bile Duct Ligation9
MALAT1-mediated EZH2 Recruitment to the GFER Promoter Region Curbs Normal Hepatocyte Proliferation in Acute Liver Injury9
Associating Preoperative MRI Features and Gene Expression Signatures of Early-stage Hepatocellular Carcinoma Patients using Machine Learning9
Identification of Expression Pattern and Clinical Significance of the Small Cajal Body-specific RNA SCARNA16 in Hepatocellular Carcinoma9
Associations Between Active, Passive Smoking and the Risk of Nonalcoholic Fatty Liver Disease9
Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma9
Establishment and Validation of a Four-stress Granule-related Gene Signature in Hepatocellular Carcinoma9
Serum Resistin as a Biomarker in Nonalcoholic Fatty Liver Disease: Is This a Road to be Taken?9
Surveillance Imaging and GAAD/GALAD Scores for Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis9
Alcohol and Metabolic-associated Fatty Liver Disease9
Late-onset Cholestasis with Paucity of Portal Area Secondary to HNF1β Deficiency in Adulthood: A Case Report9
Effectiveness of Tenofovir Alafenamide in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase and Positive Hepatitis B Virus DNA9
Hepatocellular Carcinoma and the Role of Liver Transplantation: An Update and Review9
Mesenchymal Stem Cells Alleviate Acute Liver Failure through Regulating Hepatocyte Apoptosis and Macrophage Polarization9
Hydrogen Sulfide Promotes Platelet Autophagy via PDGFR-α/PI3K/Akt Signaling in Cirrhotic Thrombocytopenia9
RASAL2 Deficiency Attenuates Hepatic Steatosis by Promoting Hepatic VLDL Secretion via the AKT/TET1/MTTP Axis9
Corrigendum: Osteopontin Promotes Macrophage M1 Polarization by Activation of the JAK1/STAT1/HMGB1 Signaling Pathway in Nonalcoholic Fatty Liver Disease8
Noninvasive Assessment of Liver Fibrosis and Inflammation in Chronic Hepatitis B: A Dual-task Convolutional Neural Network (DtCNN) Model Based on Ultrasound Shear Wave Elastography8
Progress in Biomarkers Related to Biliary Atresia8
Peripheral Blood CD4+/CD8+ T Cell Ratio Predicts HBsAg Clearance in Inactive HBsAg Carriers Treated with Peginterferon Alpha8
MicroRNA-7-5p Inhibits Migration, Invasion and Metastasis of Intrahepatic Cholangiocarcinoma by Inhibiting MyD888
Pipeline of New Drug Treatment for Non-alcoholic Fatty Liver Disease/Metabolic Dysfunction-associated Steatotic Liver Disease8
Dissecting the Contributing Role of Divergent Adipose Tissue to Multidimensional Frailty in Cirrhosis8
Metabolic-associated Fatty Liver Disease8
Exploring Circulating Tumor Cells: Detection Methods and Biomarkers for Clinical Evaluation in Hepatocellular Carcinoma8
A Molecular Hepatocellular Carcinoma Prognostic Score System Precisely Predicts Overall Survival of Hepatocellular Carcinoma Patients8
Impaired Pulmonary Function as a Potential Contributor to Reduced Exercise Capacity Associated with MAFLD8
Emerging Therapeutic Strategies in the Fight Against Primary Biliary Cholangitis8
Novel Prognostic Models for Predicting the 180-Day Outcome for Patients with Hepatitis-B Virus-related Acute-on-chronic Liver Failure8
Severe Acute Hepatitis of Unknown Origin in Children: What Do We Know Today?8
Efficacy of Vaccine Protection Against COVID-19 Virus Infection in Patients with Chronic Liver Diseases7
Portal Fibrotic Cord is Associated with Transjugular Intrahepatic Portosystemic Shunt Failure and Death in Cirrhotic Patients7
Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)7
FTO Promotes Hepatocellular Carcinoma Progression by Mediating m6A Modification of BUB1 and Targeting TGF-βR1 to Activate the TGF-β Signaling Pathway7
Stratified Analysis of Survival Benefit for ABO-incompatible Deceased-donor Liver Transplantation: Multicenter Propensity Score-matched Study7
Prognostic Impact of Surgical Margin Width in Hepatectomy for Colorectal Liver Metastasis7
Therapeutic Perspectives of IL1 Family Members in Liver Diseases: An Update7
Dynamic Humoral Immune Response to Primary and Booster Inactivated SARS-CoV-2 Vaccination in Patients with Cirrhosis7
Fucoidan Ameliorates Ferroptosis in Ischemia-reperfusion-induced Liver Injury through Nrf2/HO-1/GPX4 Activation7
MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement7
Alcoholic vs. Nonalcoholic Steatohepatitis: Vascular Branching Heterogeneity on Magnetic Resonance Imaging as a Diagnostic Marker7
A Prognostic Nomogram with High Accuracy Based on 2D-SWE in Patients with Acute-on-chronic Liver Failure7
Prognostic Performance of the China Liver Cancer Staging System in Hepatocellular Carcinoma Following Transarterial Chemoembolization7
Chinese Expert Consensus for the Management of Thrombocytopenia in Cirrhosis7
Guidelines for the Management of Cholestatic Liver Diseases (2021)7
Liver Transplantation Services During the Time of COVID-196
Effects of Transjugular Intrahepatic Portosystemic Shunt on Renal and Pulmonary Function in Hepatic Decompensation with and without Hepatorenal and Hepatopulmonary Syndromes: A Review6
Time of Liver Function Abnormal Identification on Prediction of the Risk of Anti-tuberculosis-induced Liver Injury6
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis6
Differentiating Neonatal Dubin Johnson Syndrome from Biliary Atresia: Start Simply6
Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation6
Targeting the Wnt Signaling Pathway in Liver Fibrosis for Drug Options: An Update6
Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells6
Prognostic Relevance of Metabolic Dysfunction-associated Steatohepatitis for Patients with Chronic Hepatitis B6
Hepatitis B Virus Induces Microtubule Stabilization to Promote Productive Infection through Upregulating Microtubule-associated Protein 1S6
Molecular and Histological Profiles and Relevant Imaging Signatures of Intrahepatic Cholangiocarcinoma6
Corrigendum: Ursolic Acid Modulates Estrogen Conversion to Relieve Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease via HSD17B145
Multifaceted Influence of Histone Deacetylases on DNA Damage Repair: Implications for Hepatocellular Carcinoma5
Hepatic Ischemia-reperfusion Injury in Mice was Alleviated by Rac1 Inhibition – More Than Just ROS-inhibition5
Investigating the Effect of Metabolic Phenotypes on Health Events in Alcoholic and Nonalcoholic Fatty Liver Disease5
Diagnostic and Prognostic Value of Protein Post-Translational Modifications in Hepatocellular Carcinoma5
Establishment of a Rat Model of Liver Venous Deprivation: Simultaneous Portal and Hepatic Vein Ligation5
Immune Regulatory Networks and Therapy of γδ T Cells in Liver Cancer: Recent Trends and Advancements5
Liver Lesions at Risk of Transformation into Hepatocellular Carcinoma in Cirrhotic Patients: Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement5
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD5
Prognostic Biomarkers for Hepatocellular Carcinoma Based on Serine and Glycine Metabolism-related Genes5
Critical Update on the Diagnosis and Management of COVID-19 in Advanced Cirrhosis and Liver Transplant Recipients5
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment5
Antiviral Therapy Favors a Lower Risk of Liver Cirrhosis in HBeAg-negative Chronic Hepatitis B with Normal Alanine Transaminase and HBV DNA Positivity5
Causal Relationship Between Gut Microbiota and Liver Cirrhosis: 16S rRNA Sequencing and Mendelian Randomization Analyses5
GTF3C2 Promotes the Proliferation of Hepatocellular Carcinoma Cells through the USP21/MEK2/ERK1/2 Pathway5
Systematic Evaluation of Guidelines for the Diagnosis and Treatment of Hepatitis E Virus Infection5
Transjugular Intrahepatic Portosystemic Shunt Linked to Increased Risk of Hepatocellular Carcinoma: A VA Matched Cohort Study5
Development of a Widely Applicable and Simple Prognostic Score for Patients with Acute-on-chronic Liver Failure5
COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence5
The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis5
Evaluation of Preoperative Microvascular Invasion in Hepatocellular Carcinoma Through Multidimensional Parameter Combination Modeling Based on Gd-EOB-DTPA MRI5
Augmenter of Liver Regeneration Monoclonal Antibody Promotes Apoptosis of Hepatocellular Carcinoma Cells5
MgIG Attenuates Oxaliplatin-induced Hepatotoxicity through Suppression of Connexin 43 in Hepatic Stellate Cells4
New Staging Model for Radiation-based Hepatocellular Carcinoma Treatment: A National Multicenter Study4
Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review4
Evaluation of Ultrasound-based Surveillance for Hepatocellular Carcinoma in Patients at Risk: Results From a German Multicenter Retrospective Cohort Study4
Regional and National Trends of Adult Living Donor Liver Transplantation in the United States Over the Last Two Decades4
2022 Reviewer Acknowledgement4
High Frequency of Antiviral Resistance Mutations in HBV Genotypes A2 and H: Multidrug Resistance Strains in Mexico4
Distinct Types of Cell Death and Implications in Liver Diseases: An Overview of Mechanisms and Application4
Acute Severe Hepatitis of Unknown Origin in Children Across the World: A 2022 Source of Concern4
Spindle and Kinetochore-associated Family Genes are Prognostic and Predictive Biomarkers in Hepatocellular Carcinoma4
Plasma Extracellular Vesicle-derived MicroRNA Associated with Human Alpha-1 Antitrypsin Deficiency-mediated Liver Disease4
Therapeutic Use of Viruses: Newcastle Disease Virus HK84 Oncolytic Treatment for Hepatocellular Carcinoma4
Acute Hepatitis of Unknown Origin in Children: Early Observations from the 2022 Outbreak4
Value of Non-tumoral Liver Volume in the Prognosis of Large Hepatocellular Carcinoma Patients After R0 Resection4
Change of Cytokines in Chronic Hepatitis B Patients and HBeAg are Positively Correlated with HBV RNA, Based on Real-world Study4
Journal of Clinical and Translational Hepatology Receives Its First Impact Factor (4.108) and CiteScore (6.7)4
Corrigendum: Transjugular Intrahepatic Portosystemic Shunt Linked to Increased Risk of Hepatocellular Carcinoma: A VA Matched Cohort Study4
New First-line Immunotherapy-based Therapies for Unresectable Hepatocellular Carcinoma: A Living Network Meta-analysis4
Serum Iron Overload Activates the SMAD Pathway and Hepcidin Expression of Hepatocytes via SMURF14
Comprehensive Approach to Assessment of Liver Viability During Normothermic Machine Perfusion4
Prediction and Prevention of Post-hepatectomy Liver Failure: Where Do We Stand?4
Corrigendum: RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma4
Development and Validation of a Clinical Risk Score to Predict Immune-mediated Liver Injury Caused by Sintilimab: Assessed for Causality Using Updated RUCAM4
Immunotherapy-induced Hepatotoxicity: A Review4
Carvedilol Versus Other Nonselective Beta Blockers for Variceal Bleeding Prophylaxis and Death: A Network Meta-analysis4
Indole-3-propionic Acid-aggravated CCl4-induced Liver Fibrosis via the TGF-β1/Smads Signaling Pathway4
Safety and Immunogenicity After Primary and Booster Inactivated SARS-Cov-2 Vaccination in Patients with Autoimmune Liver Diseases4
Development of a Novel Endovascular Brachytherapy Stent: A Proof-of-concept Study4
Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Review3
Sarmentosin Induces Autophagy-dependent Apoptosis via Activation of Nrf2 in Hepatocellular Carcinoma3
Role of Ras-related Nuclear Protein/Polypyrimidine Tract Binding Protein in Facilitating the Replication of Hepatitis C Virus3
Upregulation of TMCO3 Promoting Tumor Progression and Contributing to the Poor Prognosis of Hepatocellular Carcinoma3
Clinical Characteristics, Treatment Effects and Risk Factors of Liver Cirrhosis in Patients with Wilson’s Disease Hepatic Type3
Advances in the Treatment of Autoimmune Hepatitis3
Performance of Hepatitis Delta Virus (HDV) RNA Testing for the Diagnosis of Active HDV Infection: Systematic Review and Meta-analysis3
Hepatic Histoplasmosis: An Update3
RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma3
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges3
Serum Soluble Vascular Endothelial Growth Factor Receptor 1 as a Potential Biomarker of Hepatopulmonary Syndrome3
Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic3
Combination Therapies for Advanced Biliary Tract Cancer3
Pre-emptive TIPSS in Acute Variceal Bleeding: Current Status, Controversies, and Future Directions3
Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study3
Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease3
Peptidomic Analysis Reveals that Novel Peptide LDP2 Protects Against Hepatic Ischemia/Reperfusion Injury3
The Relationship between Viral Replication and the Severity of Hepatic Necroinflammatory Damage Changed before HBeAg Loss in Patients with Chronic Hepatitis B Virus Infection3
Identification and Analysis of Gut Microbiota and Functional Metabolism in Decompensated Cirrhosis with Infection3
Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update3
Guidelines for the Management of Esophagogastric Variceal Bleeding in Cirrhotic Portal Hypertension3
Unraveling the Emerging Niche Role of Hepatic Stellate Cell-derived Exosomes in Liver Diseases3
Prevalence of Hepatitis D Virus Antibody Positivity in Chinese Patients with Chronic Hepatitis B Virus Infection3
Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B: Protocol for a Phase 3 Randomized Trial3
Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment3
Symptoms Burden and Health-related Quality of Life in Chinese Patients with Primary Biliary Cholangitis3
Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis3
Defining the Value of Extracorporeal Liver Support in Acute and Acute-on-chronic Liver Failure3
COVID-19 and Liver Transplantation: Challenges and Opportunities3
Noncontrast-enhanced MRI-based Noninvasive Score for Portal Hypertension (CHESS1802): An International Multicenter Study3
High Frame Rate Contrast-enhanced Ultrasound Helps Differentiate Malignant and Benign Focal Liver Lesions3
Infections in Alcoholic Hepatitis3
Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma3
ADAMTS13 Improves Hepatic Platelet Accumulation in Pyrrolizidine Alkaloids-induced Liver Injury3
Transplantation of Mesenchymal Stem Cells Attenuates Acute Liver Failure in Mice via an Interleukin-4-dependent Switch to the M2 Macrophage Anti-inflammatory Phenotype2
Prevalence of Hepatitis B Core Antibody in Intravenous Immunoglobulin Products by Chemiluminescent Microparticle Immunoassay2
Intestinal Depletion of TM6SF2 Exacerbates High-fat Diet-induced Metabolic Dysfunction-associated Steatotic Liver Disease through the Gut-liver Axis2
Post-hepatoportoenterostomy Acoustic Radiation Force Impulse Elastography to Predict Two-year Outcome of Biliary Atresia2
Clinical Predictors of Functional Cure in Children 1–6 Years-old with Chronic Hepatitis B2
PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease2
96-Week Treatment of Tenofovir Amibufenamide and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients2
Comprehensive Bile Acid Profiling of ABCB4-mutated Patients and the Prognostic Role of Taurine-conjugated 3α,6α,7α,12α-Tetrahydroxylated Bile Acid in Cholestasis2
Clinicopathological and Prognostic Value of Programmed Cell Death 1 Expression in Hepatitis B Virus-related Hepatocellular Carcinoma: A Meta-analysis2
Novel Approaches to Inhibition of HBsAg Expression from cccDNA and Chromosomal Integrants: A Review2
Adjuvant Therapy for Hepatocellular Carcinoma After Curative Treatment: Several Unanswered Questions2
SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites2
Fluorescence-guided Surgery for Hepatocellular Carcinoma: From Clinical Practice to Laboratories2
B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection2
Pluripotent Stem Cell-derived Strategies to Treat Acute Liver Failure: Current Status and Future Directions2
The Multifaceted Role of Bilirubin in Liver Disease: A Literature Review2
An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir2
Prognostic Nomogram for Patients with Hepatitis E Virus-related Acute Liver Failure: A Multicenter Study in China2
Soluble CD163 and CD163 Expression on Monocytes Associated with Chronic Hepatitis B Inflammation and HBsAg Loss2
Therapeutic Effect of Prolyl Endopeptidase Inhibitor in High-fat Diet-induced Metabolic Dysfunction-associated Fatty Liver Disease2
The Rising Burden of Hepatocellular Carcinoma: Is the Gender Gap Narrowing?2
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)2
Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease2
“Treat-all” Strategy for Patients with Chronic Hepatitis B Virus Infection in China: Are We There Yet?2
Efficacy and Safety of Second-line Treatments in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: A Meta-analysis2
Therapeutic Value of Estrogen Receptor α in Hepatocellular Carcinoma Based on Molecular Mechanisms2
HBeAg-negative Patients with Chronic Hepatitis B Virus Infection and Normal Alanine Aminotransferase: Wait or Treat?2
Risk Factors of Chronic Kidney Disease in Chronic Hepatitis B: A Hospital-based Case-control Study from China2
Pharmacotherapy for Non-alcoholic Fatty Liver Disease Associated with Diabetes Mellitus Type 22
Mechanism of Metabolic Dysfunction-associated Steatotic Liver Disease: Important role of lipid metabolism2
Association between Metabolic Dysfunction-associated Fatty Liver Disease and Cognitive Impairment2
Artesunate Induces Ferroptosis in Hepatic Stellate Cells and Alleviates Liver Fibrosis via the ROCK1/ATF3 Axis2
Update on Sphincter of Oddi Dysfunction: A Review2
Osteopontin Promotes Macrophage M1 Polarization by Activation of the JAK1/STAT1/HMGB1 Signaling Pathway in Nonalcoholic Fatty Liver Disease2
A Blood Hepatocellular Carcinoma Signature Recognizes Very Small Tumor Nodules with Metastatic Traits2
HBx Facilitates Drug Resistance in Hepatocellular Carcinoma via CD133-regulated Self-renewal of Liver Cancer Stem Cells2
Key Points and Future Directions from the 2024 Chinese Guidelines for Fatty Liver Disease2
Fibroblast Growth Factor 19 Induced Changes in Non-malignant Cholangiocytes2
Hepatocellular Ballooning is Due to Highly Pronounced Glycogenosis Potentially Associated with Steatosis and Metabolic Reprogramming2
Emerging Roles of High-mobility Group Box-1 in Liver Disease2
Breath Biopsy® to Identify Exhaled Volatile Organic Compounds Biomarkers for Liver Cirrhosis Detection2
Trends in Mortality of Cirrhosis in China: An Analysis of the China Death Surveillance Database from 2008 to 20202
TDF Promotes Glycolysis and Mitochondrial Dysfunction to Accelerate Lactate Accumulation by Downregulating PGC1α in Mice2
CCNE1 Promotes the Progression of Hepatic Precancerous Lesion and the Malignant Phenotype of Hepatocellular Carcinoma2
Ultrasonography of Hepatocellular Carcinoma: From Diagnosis to Prognosis2
High Levels of Vitamin C Intake Modify Effects of Phthalates on Metabolic Dysfunction-associated Steatotic Liver Disease: A Nationally Representative Study2
Five-year Treatment with Tenofovir Alafenamide Achieves High Rates of Viral Suppression, Alanine Aminotransferase Normalization, and Favorable Bone and Renal Safety in Chinese Chronic Hepatitis B Pati2
Topoisomerase I Inhibition Radiosensitizing Hepatocellular Carcinoma by RNF144A-mediated DNA-PKcs Ubiquitination and Natural Killer Cell Cytotoxicity2
NASH Drug Development: Seeing the Light at the End of the Tunnel?2
Sending an SOS: Healing the Liver with the Bone Marrow2
Functional Cure of Chronic Hepatitis B with Antiviral Treatment in Children having High-level Viremia and Normal or Mildly Elevated Serum Aminotransferase2
Efficacy and Safety of Sofosbuvir-based Regimens in Hepatitis C Patients With Decompensated Cirrhosis: A Systematic Review and Meta-analysis2
Update on the Diagnosis and Treatment of Combined Hepatocellular Cholangiocarcinoma2
Clinical and Genetic Characteristics of Alagille Syndrome in Adults1
E2F1-mediated Up-regulation of NCAPG Promotes Hepatocellular Carcinoma Development by Inhibiting Pyroptosis1
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence1
Overexpression of RBM34 Promotes Tumor Progression and Correlates with Poor Prognosis of Hepatocellular Carcinoma1
Development of an Eight-gene Prognostic Model for Overall Survival Prediction in Patients with Hepatocellular Carcinoma1
IGF2-NR4A2 Signaling Regulates Macrophage Subtypes to Attenuate Liver Cirrhosis1
0.43516993522644